Americans for Safe Access

JULY 29, 2020

Oregon is one of the few but growing number of states that have both a medical cannabis program and an adult use (recreational) program, and users of cannabis medicine can be found in either group.

Programs 246

Programs Therapy Medicine Patients 246

NORML

MAY 27, 2020

Members voted 28 to 6 in favor of an amended version of House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Conditions 282

Conditions Legislation Therapy Patients 282

NORML

APRIL 25, 2019

Doug Burgum signed legislation on Wednesday amending and expanding the state’s nascent medical cannabis access program. Though approved by voters in November 2016, the state’s medical cannabis access program is not yet fully operational. Republican Gov.

Law 203

Law Therapy Legislation Programs 203

Cannabis Law Report

JUNE 16, 2021

This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Santé Cannabis is at the forefront of safe and supported patient access to complementary medicines.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

NORML

JUNE 10, 2020

” Furthermore, pain patients enrolled in medical cannabis access programs typically report decreasing or even eliminating their use of opiates after initiating cannabis therapy. percent in 2016).” ” Public comments “are part of the public record and are subject to public disclosure.

Chronic Pain 256

Chronic Pain Therapy Patients Topical 256

NORML

JUNE 1, 2020

On Sunday, legislators finalized HB 819 , which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.” John Bel Edwards.

Access 208

Access Therapy Legislation Patients 208

NORML

NOVEMBER 25, 2019

.” The findings are consistent with those of prior studies — such as those here , here , and here — which report that pain patients reduce their use of opioids following access to medical cannabis therapy.

Chronic Pain 219

Chronic Pain Patients Therapy Data 219

NORML

JULY 2, 2019

Phil Murphy signed legislation into law today significantly amending and expanding the state’s medical cannabis access program. Assembly Bill 20 , The Jake Honig Compassionate Use Medical Cannabis Act, institutes various changes to the program to better facilitate patients’ access to the substance.

Law 175

Law Chronic Pain Epilepsy Programs 175

NORML

MARCH 18, 2019

It expands the pool of patients eligible for cannabis therapy to include those diagnosed with post-traumatic stress, severe chronic pain, Crohn’s disease, Lou Gehrig’s disease, sleep apnea, and neuropathy, among other newly specified conditions. Once signed into law, the reduced penalties take effect on July 1, 2019.

Decriminalization 236

Decriminalization Chronic Pain Marijuana Legislation 236

NORML

APRIL 29, 2019

House and Senate lawmakers have approved legislation, House File 732 , to expand the state’s medical cannabis access program. The measure now awaits action from Republican Gov. Kim Reynolds. Under existing law , licensed dispensaries may only dispense plant-derived extracts possessing CBD and no more than three percent THC.

Legislation 161

Legislation Therapy THC Extraction 161

Medical Marijuana Pages

JUNE 10, 2024

In a groundbreaking decision, Connecticut Expands Medical Marijuana Program to Include Autism (ASD). To its list of qualifying conditions for the state’s medical marijuana program. And offers hope to countless families seeking alternative therapies for managing autism symptoms. The inclusion of autism.

Programs 70

Programs Therapy Marijuana Treatment 70

Veriheal

JANUARY 9, 2024

Their newest bipartisan bill will push this agenda by creating a framework for mental health providers to offer psilocybin-assisted therapy to military veterans and first responders battling mental illnesses like post-traumatic stress disorder (PTSD), anxiety, depression, and more.

Therapy 64

Therapy Legalization Treatment Decriminalization 64

Cannabis Law Report

MAY 19, 2022

This is Numinus’ first psilocybin-assisted therapy treatment outside of ongoing clinical trials, and among the first to use of this regulatory mechanism through Health Canada’s Special Access Program (“SAP”), which was amended January 5 th , 2022 to include access to psychedelic compounds on a case-by-case basis.

Therapy 52

Therapy Treatment Clinical Trials Access 52

NORML

JUNE 13, 2019

All of the state programs are independent and in various stages of maturity. Many are having serious difficulty calculating and covering annual expenses for marijuana therapy. Are you paying too much for medical marijuana? Prices, even for closely similar products, have a wide range.

Marijuana 277

Marijuana Dispensary Patients Retail 277

Veriheal

JUNE 29, 2021

In the last 100 years, many of the plant therapies that were embraced in history were outlawed by governments around the world and replaced by lab-made synthetic drugs we label medicine. The FDA refers to this program as the expanded access program on their website. Cannabinoid Therapies for Cancer Patients.

Therapy 64

Therapy DEA Patients Clinical Trials 64

Cannabis Law Report

MARCH 29, 2023

. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched the Numinus Certification Pathway – a collection of psychedelic-assisted therapy (“PAT”) training courses (..)

Therapy 52

Therapy Programs Collective Treatment 52

NORML

FEBRUARY 23, 2020

Legislation is pending, Senate Bill 165, to establish a medical marijuana access program for qualified patients with a physician’s recommendation to access medical marijuana from licensed retail outlets. Legislation is pending, Senate Bill 1015, to make participation in Virginia’s medical cannabis program legal under state law.

Legislation 252

Legislation Patients Decriminalization Access 252

NORML

JANUARY 24, 2019

Last year we passed unanimously the historic Let Doctors Decide bill that expanded patient access to our medical cannabis program,” said Senator Dunnavant, a medical doctor from Henrico. “We Patient access is critical to the success of Virginia’s medical cannabis program,” said Jenn Michelle Pedini, executive director of Virginia NORML.

Policy 179

Policy Patients Education Legislation 179

The Cannigma

AUGUST 5, 2022

2 In 2019 the FDA approved a keta m ine-based nasal spray to treat depression that does not respond to other therapies. A 2022 study of 1247 people using at-home ketamine-assisted therapy found that 62% of participants reported a 50%+ improvement in depressive symptoms. But this program offers more than just the ketamine itself.

Treatment 141

Treatment Research and Development Therapy Digestion 141

Cannabis Law Report

MARCH 15, 2021

David Bronner calls out the never ending creep of Compass or as he puts it…… Their monopolistic and shady… Read More.

Therapy 64

Therapy Programs 64

Cannabis Law Report

JUNE 23, 2021

In addition to the pilot program, the parties are working toward an exclusive, definitive supply and distribution agreement, which, if entered into, is expected to position Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. to reach 3.2 billion euros ($3.75 billion) by 2025. 310.299.1717 Office.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

MAY 1, 2023

million to support the development of its MDMA-assisted therapy program in a tranche led by Sixty Two Capital and Taylor Collison. Biotech Emyria (ASX: EMD) has raised $2.5

Therapy 52

Therapy Programs 52

Veriheal

JANUARY 18, 2024

Cannabis nurses are crucial in bridging the gap between traditional healthcare and emerging cannabis therapies. These nurses also offer valuable insights on integrating cannabis therapies into various healthcare settings, including dispensaries, primary care clinics, and specialized pain management centers. So what does it all mean?

Education 116

Education Therapy Patients Research and Development 116

NORML

JANUARY 11, 2019

At the state level, Governor Jay Inslee of Washington launched a new program and began granting pardons to those with past criminal misdemeanor marijuana-related convictions on their record. Legislation is pending, House Bill 366, to permit physicians to recommend cannabis therapy to those struggling with opioid addiction, misuse, or abuse.

Legislation 217

Legislation Decriminalization Hemp Patients 217

NORML

FEBRUARY 5, 2019

It’s vital that we speak as one voice for a medical program.” Jason Nemes, R-33, is sponsoring a medical cannabis bill (HB 136) that allows doctors to recommend cannabis therapy as part of patients’ treatment regimens. KY4MM has been extremely important in helping to get all of our supporters to come together.

Decriminalization 208

Decriminalization Legislation Treatment Therapy 208

NORML

MARCH 1, 2019

Denver, Colorado’s marijuana social use law is here to stay, as the city council voted this week to remove the “sunset” provision which made it a temporary four year program. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed.

Legislation 187

Legislation Compliance Compliance Hemp 187

Cannabis Law Report

MAY 19, 2022

5 restored its “Special Access Program” — abolished under former prime minister Stephen Harper in 2013 — allowing health-care experts to request access to restricted drugs that have not yet been authorized for sale in the country. “The therapy part has a capital T in this whole process,” Hartle said.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

FEBRUARY 24, 2022

Canada recently amended its Controlled Drugs and Substances Act (CDSA) to allow for psilocybin and MDMA therapy in limited circumstances. Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Conclusion.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

OCTOBER 20, 2021

International Summit on Psychedelic Therapies for Mental Illness 17-20 November 2021. The event will also feature a two-day pre-Summit Introductory Workshop Program (17-18 November) led by Nigel Denning, Dr Tra-ill Dowie with world-leading therapist trainer Dr Bill Richards (USA) from Johns Hopkins University.

Therapy 52

Therapy Medicine Topical Events 52

Cannabis Law Report

MAY 17, 2023

Marijuana Moment reports A North Carolina House committee has approved a bill to create a $5 million grant program to support research into the therapeutic potential of psilocybin and MDMA and to create a Breakthrough Therapies Research Advisory Board to oversee the effort. Edward Goodwin (R) and other […]

Therapy 98

Therapy Legislation Programs Marijuana 98

NORML

FEBRUARY 1, 2019

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Last session, the measure was vetoed by Governor Brown. CA resident?

Legislation 180

Legislation Decriminalization Access Patients 180

Cannabis Law Report

JULY 13, 2022

Physicians and researchers are urging New Mexico legislators to allow the use of psychedelic mushrooms in mental health therapy aimed at overcoming depression, anxiety, psychological trauma and alcoholism. He warned legislators that public interest is spawning illicit, underground experimentation without safeguards. “I

Therapy 52

Therapy Legislation Access Decriminalization 52

Veriheal

JULY 18, 2023

The Grant Program Details The heart of this landmark legislation lies in the development of a robust grant program. Notably, the grant program will target three prevalent and often debilitating conditions in military personnel: PTSD, traumatic brain injury (TBI) , and chronic traumatic encephalopathy (CTE).

Treatment 98

Treatment Clinical Trials Research and Development Legislation 98

Cannabis Law Report

MARCH 27, 2023

. (“ATMA”), Canada’s leading psychedelic-assisted therapy training provider, begins its first psychedelic training program highly focused on psilocybin and MDMA, designed for physicians, psychiatrists and prescribers starting April 14, 2023.

Programs 52

Programs Therapy 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

MAY 6, 2021

EMDMA-001 has been modelled on a major Phase III clinical trial developed by the Multidisciplinary Association for Psychedelic Studies (MAPS).… … Read More.

Clinical Trials 59

Clinical Trials Therapy Programs Medicine 59

NORML

JANUARY 18, 2019

Legislation is pending, House Bill 37, to permit physicians to recommend cannabis therapy to those struggling with opioid abuse or dependence. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. AK resident? HI resident? CO resident? AZ resident?

Legislation 180

Legislation Decriminalization Access Therapy 180